390 related articles for article (PubMed ID: 18208811)
21. Impaired generation of bone marrow CD34-derived dendritic cells with low peripheral blood subsets in patients with myelodysplastic syndrome.
Micheva I; Thanopoulou E; Michalopoulou S; Kakagianni T; Kouraklis-Symeonidis A; Symeonidis A; Zoumbos N
Br J Haematol; 2004 Sep; 126(6):806-14. PubMed ID: 15352984
[TBL] [Abstract][Full Text] [Related]
22. Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?
Veltroni M; Sainati L; Zecca M; Fenu S; Tridello G; Testi AM; Merlone AD; Buldini B; Leszl A; Lo Nigro L; Longoni D; Bernini G; Basso G;
Pediatr Blood Cancer; 2009 Mar; 52(3):357-63. PubMed ID: 19061215
[TBL] [Abstract][Full Text] [Related]
23. Low-Grade Myelodysplastic Syndromes with Preserved CD34+ B-Cell Precursors (CD34+ Hematogones).
Chen Z; Ok CY; Wang W; Goswami M; Tang G; Routbort M; Jorgensen JL; Medeiros LJ; Wang SA
Cytometry B Clin Cytom; 2020 Jan; 98(1):36-42. PubMed ID: 31211490
[TBL] [Abstract][Full Text] [Related]
24. Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes.
Cherian S; Moore J; Bantly A; Vergilio JA; Klein P; Luger S; Bagg A
Cytometry B Clin Cytom; 2005 Mar; 64(1):9-17. PubMed ID: 15668954
[TBL] [Abstract][Full Text] [Related]
25. Association between phenotypic features of blasts and the blast percentage in bone marrow of patients with myelodysplastic syndromes.
Ogata K; Satoh C; Hyodo H; Tamura H; Dan K; Yoshida Y
Leuk Res; 2004 Nov; 28(11):1171-5. PubMed ID: 15380341
[TBL] [Abstract][Full Text] [Related]
26. Immunophenotypic analysis of myelodysplastic syndromes.
Del Cañizo MC; Fernández ME; López A; Vidriales B; Villarón E; Arroyo JL; Ortuño F; Orfao A; San Miguel JF
Haematologica; 2003 Apr; 88(4):402-7. PubMed ID: 12681967
[TBL] [Abstract][Full Text] [Related]
27. [The role of hematopoietic growth factors on extensive apoptosis of myelodysplastic hematopoietic cells and its clinical significance].
Cao Z; Li R; Li Q
Zhonghua Xue Ye Xue Za Zhi; 1998 Jan; 19(1):27-30. PubMed ID: 10921099
[TBL] [Abstract][Full Text] [Related]
28. Immunophenotypic analysis of bone marrow B lymphocyte precursors (hématogones) by flow cytometry.
Braham Jmili N; Nsaibia S; Jacob MC; Omri H; Laatiri MA; Yacoub S; Braham Y; Aouni M; Kortas M
Clin Lab Sci; 2009; 22(4):208-15. PubMed ID: 19967915
[TBL] [Abstract][Full Text] [Related]
29. Use of a Blast Dominance-Hematogone Index for the Flow Cytometric Evaluation of Myelodysplastic Syndrome (MDS).
Schenkel JM; Hergott CB; Dudley G; Drew M; Charest K; Dorfman DM
Am J Clin Pathol; 2019 May; 151(6):584-592. PubMed ID: 30854558
[TBL] [Abstract][Full Text] [Related]
30. [Abnormalities of CD34+ cells differentiation and bone marrow cell cycle in myelodysplastic syndrome].
Li LJ; Fu R; Shao ZH; Wang HQ; Yue LZ; Ruan EB; Liu H; Wang J; Wang HL
Zhonghua Nei Ke Za Zhi; 2010 Nov; 49(11):963-6. PubMed ID: 21211213
[TBL] [Abstract][Full Text] [Related]
31. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
Wu LY; Li X; Chang CK; Ying SX; Pu Q
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
[TBL] [Abstract][Full Text] [Related]
32. Qualitative flow cytometric analysis of Malaysian myelodysplastic syndromes (MDS) patients.
Mohadese Hashem B; Rajesh R; Sabariah MN; Zainina BS
Med J Malaysia; 2012 Feb; 67(1):77-80. PubMed ID: 22582553
[TBL] [Abstract][Full Text] [Related]
33. Telomerase activity in myelodysplastic syndromes.
Gürkan E; Tanriverdi K; Başlamişli F
Leuk Res; 2005 Oct; 29(10):1131-9. PubMed ID: 16111531
[TBL] [Abstract][Full Text] [Related]
34. Quantitative assessment of myeloid nuclear differentiation antigen distinguishes myelodysplastic syndrome from normal bone marrow.
McClintock-Treep SA; Briggs RC; Shults KE; Flye-Blakemore LA; Mosse CA; Jagasia MH; Shinar AA; Dupont WD; Stelzer GT; Head DR
Am J Clin Pathol; 2011 Mar; 135(3):380-5. PubMed ID: 21350091
[TBL] [Abstract][Full Text] [Related]
35. Hematogone hyperplasia in copper deficiency.
Sutton L; Vusirikala M; Chen W
Am J Clin Pathol; 2009 Aug; 132(2):191-9; quiz 307. PubMed ID: 19605813
[TBL] [Abstract][Full Text] [Related]
36. [Diagnosis and therapy strategy in myelodysplastic syndromes].
Gattermann N; Aul C
Praxis (Bern 1994); 1996 Jan; 85(3):39-44. PubMed ID: 8578048
[TBL] [Abstract][Full Text] [Related]
37. DNA content of granulocytes, monocytes, and lymphocytes in the bone marrow smears of patients with myelodysplastic syndromes.
Widell S; Hast R; Cox C; Auer G; Bennett JM
Am J Hematol; 2001 Jun; 67(2):112-8. PubMed ID: 11343383
[TBL] [Abstract][Full Text] [Related]
38. Fas/Fas-ligand expressions in peripheral-blood mononuclear cells of patients with myelodysplastic syndromes.
Hirano T; Hiratsuka N; Iwahori T; Oka K; Wakasugi K
Res Commun Mol Pathol Pharmacol; 2003; 113-114():315-28. PubMed ID: 15686130
[TBL] [Abstract][Full Text] [Related]
39. Hematogones in immune thrombocytopenic purpura: diagnostic implication.
Akyay A; Falay M; Oztürkmen S; Biçakci Z; Tavil B; Ozet G; Olcay L
Turk J Pediatr; 2011; 53(2):219-24. PubMed ID: 21853665
[TBL] [Abstract][Full Text] [Related]
40. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
